|
|
||||||||
/
mice with cardiac
hypertrophy and fibrosis
1 Department of Medicine, Christchurch School of Medicine, Christchurch, New Zealand; and 2 Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7525
Atrial natriuretic peptide (ANP) and
brain natriuretic peptide (BNP) are cardiac hormones that regulate
blood pressure and volume, and exert their biological actions via the
natriuretic peptide receptor-A gene (Npr1). Mice lacking
Npr1 (Npr
/
) have marked cardiac
hypertrophy and fibrosis disproportionate to their increased blood
pressure. This study examined the relationships between ANP and BNP
gene expression, immunoreactivity and fibrosis in cardiac tissue,
circulating ANP levels, and ANP and BNP mRNA during embryogenesis in
Npr1
/
mice. Disruption of the
Npr1 signaling pathway resulted in augmented ANP and BNP
gene and ANP protein expression in the cardiac ventricles, most
pronounced for ANP mRNA in females [414 ± 57 in
Npr1
/
ng/mg and 124 ± 25 ng/mg in
wild-type (WT) by Taqman assay, P < 0.001]. This
increased expression was highly correlated to the degree of cardiac
hypertrophy and was localized to the left ventricle (LV) inner free
wall and to areas of ventricular fibrosis. In contrast, plasma ANP was
significantly greater than WT in male but not female
Npr1
/
mice. Increased ANP and BNP gene
expression was observed in Npr1
/
embryos
from 16 days of gestation. Our study suggests that cardiac ventricular
expression of ANP and BNP is more closely associated with local
hypertrophy and fibrosis than either systemic blood pressure or
circulating ANP levels.
atrial natriuretic peptide; brain natriuretic peptide
This article has been cited by other articles:
![]() |
E. Vellaichamy, D. Zhao, N. Somanna, and K. N. Pandey Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy Physiol Genomics, October 19, 2007; 31(2): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Januzzi Jr, W. F. Peacock, A. S. Maisel, C. U. Chae, R. L. Jesse, A. L. Baggish, M. O'Donoghue, R. Sakhuja, A. A. Chen, R. R.J. van Kimmenade, et al. Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea: Results From the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study J. Am. Coll. Cardiol., August 14, 2007; 50(7): 607 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rose, N. Hatano, S. Ohya, Y. Imaizumi, and W. R. Giles C-type natriuretic peptide activates a non-selective cation current in acutely isolated rat cardiac fibroblasts via natriuretic peptide C receptor-mediated signalling J. Physiol., April 1, 2007; 580(1): 255 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Watanabe, J. Shite, H. Takaoka, T. Shinke, Y. Imuro, T. Ozawa, H. Otake, D. Matsumoto, D. Ogasawara, O. L. Paredes, et al. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure Eur. Heart J., April 1, 2006; 27(7): 832 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. H. Christoffersen, M. Aplin, C. C. Strom, S. P. Sheikh, O. Skott, P. K. Busk, S. Haunso, and L. B. Nielsen Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1635 - H1641. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Patel, M. L. Valencik, A. M. Pritchett, J. C. Burnett Jr., J. A. McDonald, and M. M. Redfield Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H777 - H784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chilton, S. Ohya, D. Freed, E. George, V. Drobic, Y. Shibukawa, K. A. MacCannell, Y. Imaizumi, R. B. Clark, I. M. C. Dixon, et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2931 - H2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jarai, N. Iordanova, R. Jarai, A. Raffetseder, W. Woloszczuk, M. Gyongyosi, G. Geyer, J. Wojta, and K. Huber Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide Eur. Heart J., February 1, 2005; 26(3): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |